Navigating the Boom: Legal and Structural Realities of Private Equity in Cosmetic Medicine

By: Mark Opara (Healthcare and M&A Partner at Seigfreid Bingham, P.C.)

The market for corporate investment in medspas, dermatology, and cosmetic practices remains one of the most active sectors in healthcare private equity (PE). Driven by high cash-pay revenue, fragmented markets, and strong consumer demand, PE funds continue to aggressively roll up clinical practices.
(more…)